153 related articles for article (PubMed ID: 3917479)
1. Epidermal cells synthesize a cytokine with interleukin 3-like properties.
Luger TA; Wirth U; Köck A
J Immunol; 1985 Feb; 134(2):915-9. PubMed ID: 3917479
[TBL] [Abstract][Full Text] [Related]
2. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
Luger TA; Uchida A; Köck A; Colot M; Micksche M
J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
[TBL] [Abstract][Full Text] [Related]
3. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
Luger TA; Sztein MB; Schmidt JA; Murphy P; Grabner G; Oppenheim JJ
Fed Proc; 1983 Jul; 42(10):2772-6. PubMed ID: 6602721
[TBL] [Abstract][Full Text] [Related]
4. Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.
Luger TA; Stadler BM; Luger BM; Mathieson BJ; Mage M; Schmidt JA; Oppenheim JJ
J Immunol; 1982 May; 128(5):2147-52. PubMed ID: 6801132
[TBL] [Abstract][Full Text] [Related]
5. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.
Kirnbauer R; Köck A; Schwarz T; Urbanski A; Krutmann J; Borth W; Damm D; Shipley G; Ansel JC; Luger TA
J Immunol; 1989 Mar; 142(6):1922-8. PubMed ID: 2784142
[TBL] [Abstract][Full Text] [Related]
6. Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).
Luger TA; Stadler BM; Katz SI; Oppenheim JJ
J Immunol; 1981 Oct; 127(4):1493-8. PubMed ID: 6974195
[TBL] [Abstract][Full Text] [Related]
7. UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity.
Schwarz T; Urbanska A; Gschnait F; Luger TA
J Immunol; 1987 Mar; 138(5):1457-63. PubMed ID: 3492552
[TBL] [Abstract][Full Text] [Related]
8. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.
Sauder DN; Mounessa NL; Katz SI; Dinarello CA; Gallin JI
J Immunol; 1984 Feb; 132(2):828-32. PubMed ID: 6361134
[TBL] [Abstract][Full Text] [Related]
9. An epidermal cell-derived cytokine triggers the in vivo synthesis of serum amyloid A by hepatocytes.
Sztein MB; Luger TA; Oppenheim JJ
J Immunol; 1982 Jul; 129(1):87-90. PubMed ID: 7045226
[TBL] [Abstract][Full Text] [Related]
10. Desensitization of animals to the inflammatory effects of ultraviolet radiation is mediated through mechanisms which are distinct from those responsible for endotoxin tolerance.
Gahring LC; Daynes RA
J Immunol; 1986 Apr; 136(8):2868-74. PubMed ID: 2420872
[TBL] [Abstract][Full Text] [Related]
11. Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activity.
Danner M; Luger TA
J Invest Dermatol; 1987 Apr; 88(4):353-61. PubMed ID: 2435814
[TBL] [Abstract][Full Text] [Related]
12. Characterization of immunoregulatory cytokines produced by epidermal cells.
Luger TA; Köck A; Danner M
Scand J Immunol; 1985 May; 21(5):455-62. PubMed ID: 3890150
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes of the brain synthesize interleukin 3-like factors.
Frei K; Bodmer S; Schwerdel C; Fontana A
J Immunol; 1985 Dec; 135(6):4044-7. PubMed ID: 3934273
[TBL] [Abstract][Full Text] [Related]
14. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
15. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.
Razin E; Ihle JN; Seldin D; Mencia-Huerta JM; Katz HR; LeBlanc PA; Hein A; Caulfield JP; Austen KF; Stevens RL
J Immunol; 1984 Mar; 132(3):1479-86. PubMed ID: 6198393
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a keratinocyte-derived T cell growth factor distinct from interleukin 2 and B cell stimulatory factor 1.
Coleman DL; Kupper TS; Flood PM; Fultz CC; Horowitz MC
J Immunol; 1987 May; 138(10):3314-8. PubMed ID: 3494765
[TBL] [Abstract][Full Text] [Related]
18. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.
Ihle JN; Keller J; Oroszlan S; Henderson LE; Copeland TD; Fitch F; Prystowsky MB; Goldwasser E; Schrader JW; Palaszynski E; Dy M; Lebel B
J Immunol; 1983 Jul; 131(1):282-7. PubMed ID: 6190911
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family.
Kuna P; Reddigari SR; Schall TJ; Rucinski D; Sadick M; Kaplan AP
J Immunol; 1993 Mar; 150(5):1932-43. PubMed ID: 7679699
[TBL] [Abstract][Full Text] [Related]
20. Thymoma production of T cell growth factor (Interleukin 2).
Farrar JJ; Fuller-Farrar J; Simon PL; Hilfiker ML; Stadler BM; Farrar WL
J Immunol; 1980 Dec; 125(6):2555-8. PubMed ID: 6968789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
